Archives

ERN ReCONNET is pleased to announce the first series of scientific and educational events endorsed for 2026. These meetings reflect our continued commitment to fostering collaboration, advancing [...]

The registration for the European Conference on Rare Diseases & Orphan Drugs (ECRD 2026) is officially open! 🗓️ 🌍 ECRD is a leading event dedicated to the rare disease community, bringing [...]

We are happy to share the latest ERN ReCONNET newsletter (December 2025 edition) with our community! This issue looks back at a very active year for the network and brings together updates, [...]

The Undifferentiated Connective Tissue Disease (UCTD) Disease Group is pleased to welcome Chiara Tani, who, alongside Cristina Pamfil and ePAG Ramona Luciu, joins the coordination of the [...]

The year 2025 has been a period of significant productivity for the Systemic Sclerosis (SSc) Disease Group, marked by the completion of key projects and the launch of initiatives vital to [...]

The year 2025 has been a period of significant momentum and consolidation for the Sjögren’s Disease (SjD) Group, during which projects launched progressed significantly thanks to dynamic [...]

The year 2025 has been a period of significant progress for the Mixed Connective Tissue Disease (MCTD) Disease Group, marked by the completion of major educational and research milestones. A [...]

Throughout 2025, the ERN ReCONNET Idiopathic Inflammatory Myopathies (IIMs) Disease Group has achieved significant milestones in education, clinical research, and data standardization. A [...]

The main successes achieved include the launch of the initiative “ERN ReCONNET points to consider for the use of imaging in IgG4-RD“. This project aims to create a position statement [...]

Throughout 2025, the ERN ReCONNET Ehlers-Danlos Syndromes (EDS) Disease Group has significantly advanced its efforts to refine the diagnosis and management of generalized joint hypermobility [...]